Furthermore, analyses of hepatic toxicity in humans and animals did not indicate strong association between OATP inhibition and hyperbilirubinemia, neither for humans nor for animals (Kotsampasakou et al., 2017b). Here, SLCO1A2 is linked to Hyperbilirubinemia.